The Coronavirus Pandemic liveCovid-19 Updates Coronavirus Map and Cases Covid’s Last Surge? Vaccination Tracker Vaccine FAQ Advertisement Continue reading the main story Supported by Continue reading the main story Data From Federal Scientists Raise Questions About J.&J. Booster Shots People who have received the company’s one-shot vaccine may benefit from a booster with another brand. F.D.A.… Read More »
A former Oklahoma resident got married and while trying to change her last name on her Texas driver’s license, found out she was a wanted woman in her old state. “I went to change my driver’s license, during this COVID thing you had to make an appointment, and so, I sent them an email (and)… Read More »
Busy launching several new drugs, RNA biotech Alnylam posted a big revenue increase in 2020—and it expects more growth in 2021, partly thanks to its top-selling Onpattro drug. But now the U.S. Department of Justice is investigating its marketing practices for that very product. The U.S. Department of Justice subpoenaed the biotech last week, demanding documents that detail its Onpattro marketing… Read More »
The final 2020-2025 Federal Health IT Strategic Plan released today by the Office of the National Coordinator for Health IT is laser focused – unsurprisingly, given the goals of recent rulemakings – on ensuring Americans’ easy access to their own electronic health information. ONC worked with more than two dozen federal organizations and drew upon… Read More »
Rep. Jim Clyburn, D-S.C., Friday on CNBC hinted that there could be illegal activity behind the Trump administration’s backing of a number of pharmaceutical companies’ Covid-19 vaccine developments. “We see some things that indicate that there may be some insider stuff going on that’s benefiting one or two people without regard to what we’re really… Read More »
Only days after former BARDA chief Rick Bright filed a whistleblower complaint alleging retaliation by the Trump administration, the U.S. Office of the Special Counsel has recommended his temporary reinstatement, the New York Times reports. The agency found “reasonable grounds to believe” HHS officials were retaliating against Bright when they re-assigned him to a new public-private… Read More »